Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

CSF markers for incipient Alzheimer's disease.

Blennow K, Hampel H.

Lancet Neurol. 2003 Oct;2(10):605-13. Review.

PMID:
14505582
2.

CSF biomarkers for mild cognitive impairment.

Blennow K.

J Intern Med. 2004 Sep;256(3):224-34. Review.

3.

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease.

Blennow K, Vanmechelen E, Hampel H.

Mol Neurobiol. 2001 Aug-Dec;24(1-3):87-97. Review.

PMID:
11831556
4.

[Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].

Shoji M.

Brain Nerve. 2012 May;64(5):497-504. Review. Japanese.

PMID:
22570063
5.
6.

Biological markers of Alzheimer's disease.

de Souza LC, Sarazin M, Teixeira-Júnior AL, Caramelli P, Santos AE, Dubois B.

Arq Neuropsiquiatr. 2014 Mar;72(3):227-31. Review.

7.

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.

Andreasen N, Blennow K.

Clin Neurol Neurosurg. 2005 Apr;107(3):165-73. Review.

PMID:
15823670
8.

Clinical indications for analysis of Alzheimer's disease CSF biomarkers.

Engelborghs S.

Rev Neurol (Paris). 2013 Oct;169(10):709-14. doi: 10.1016/j.neurol.2013.07.024. Epub 2013 Sep 6. Review.

PMID:
24016466
9.

CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.

Andreasen N, Sjögren M, Blennow K.

World J Biol Psychiatry. 2003 Oct;4(4):147-55. Review.

PMID:
14608585
10.

Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

Zetterberg H, Blennow K.

J Alzheimers Dis. 2013;33 Suppl 1:S361-9. Review.

PMID:
22710917
11.

Cerebrospinal fluid biomarkers for Alzheimer's disease.

Blennow K, Zetterberg H.

J Alzheimers Dis. 2009;18(2):413-7. doi: 10.3233/JAD-2009-1177. Review.

PMID:
19661632
12.
15.

Fluid biomarkers in Alzheimer's disease - current concepts.

Rosén C, Hansson O, Blennow K, Zetterberg H.

Mol Neurodegener. 2013 Jun 21;8:20. doi: 10.1186/1750-1326-8-20. Review.

16.

[Biomarker of dementia: clinical and preclinical diagnosis].

Shoji M.

Nihon Rinsho. 2012 May;70(5):857-63. Review. Japanese.

PMID:
22620013
17.

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.

Blennow K.

Expert Rev Mol Diagn. 2005 Sep;5(5):661-72. Review.

PMID:
16149870
18.

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.

Hampel H, Mitchell A, Blennow K, Frank RA, Brettschneider S, Weller L, Möller HJ.

J Neural Transm (Vienna). 2004 Mar;111(3):247-72. Epub 2003 Dec 3. Review.

PMID:
14991453
19.

[Alzheimer's disease as brain amyloidosis: diagnosis using cerebrospinal fluid abeta and tau].

Shoji M.

Rinsho Byori. 2006 May;54(5):503-8. Review. Japanese.

PMID:
16789421
20.

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren M, Andreasen N, Blennow K.

Clin Chim Acta. 2003 Jun;332(1-2):1-10. Review.

PMID:
12763273

Supplemental Content

Support Center